Alexander Sigalov
Shrewsbury, MA (USA)
Role(s):
Founder/Owner/Principal
SignaBlok
Find More Startups
Startup
Location:
Shrewsbury
Industry:
Bio-Technology
Year Founded:
2009
Number Employees:
1-10 people
Description:
SignaBlok, Inc. is a Massachusetts-based life sciences and biotechnology company that develops next generation therapeutics to treat a variety of large market diseases with unmet needs: thrombosis, sepsis, dermatitis, arthritis, Crohn's disease, lupus, multiple sclerosis, organ transplantation, etc. Due to highly innovative features of the SCHOOL technology, SignaBlok’s solution is positioned to disrupt the market(s), rather than sustain it with incrementally improved products. The novel mechanism also opens a new IP space. Our commitment to high quality innovation, science and management expertise, encouraging results, our impressive IP portfolio, our growing involvement in international efforts to address unmet medical needs place us on a fast-track to success.